Exin Therapeutics says AI chose gene therapy for mouse brain surgery
Exin Therapeutics CEO says AI chose gene therapy vector, dosage, and brain region before controlling robotic surgery rig
Exin Therapeutics, a biotech startup, claims it has successfully used an AI agent to perform brain surgery on a mouse, with the AI selecting the gene therapy vector, dosage, and brain region before driving a robotic injection rig.